Product NDC: | 0338-1077 |
Proprietary Name: | Dobutamine Hydrochloride in Dextrose |
Non Proprietary Name: | Dobutamine Hydrochloride |
Active Ingredient(s): | 400 mg/100mL & nbsp; Dobutamine Hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0338-1077 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020255 |
Marketing Category: | NDA |
Start Marketing Date: | 19930923 |
Package NDC: | 0338-1077-02 |
Package Description: | 250 mL in 1 BAG (0338-1077-02) |
NDC Code | 0338-1077-02 |
Proprietary Name | Dobutamine Hydrochloride in Dextrose |
Package Description | 250 mL in 1 BAG (0338-1077-02) |
Product NDC | 0338-1077 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dobutamine Hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19930923 |
Marketing Category Name | NDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | DOBUTAMINE HYDROCHLORIDE |
Strength Number | 400 |
Strength Unit | mg/100mL |
Pharmaceutical Classes | Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] |